Cargando…

S132. SAMPLING BIAS IN STUDIES OF FIRST-EPISODE PSYCHOSIS – A FOLLOW-UP STUDY

BACKGROUND: Attrition rates and sampling bias in controlled clinical studies are a concern when evaluating the relevance of the results to a specific patient population in a real-life clinical / treatment setting. Dropout rates in studies on psychotic disorders are high and many eligibility criteria...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walta, Maija, Laurikainen, Heikki, Armio, Reetta-Liina, From, Tiina, Salokangas, Raimo K R, Hietala, Jarmo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session I
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234582/ http://dx.doi.org/10.1093/schbul/sbaa031.198

Ejemplares similares

S170. AMYGDALA SUBNUCLEI VOLUMES IN FIRST-EPISODE PSYCHOSIS: ASSOCIATION WITH CHILDHOOD ADVERSITY
por: Armio, Reetta-Liina, et al.
Publicado: (2018)

Short-term functional outcome in psychotic patients: results of the Turku early psychosis study (TEPS)
por: Salokangas, Raimo K. R., et al.
Publicado: (2021)

Sense of mastery in first-episode psychosis—a one-year follow-up study
por: Lindgren, Maija, et al.
Publicado: (2023)

Extrapyramidal symptoms predict cognitive performance after first-episode psychosis
por: Lindgren, Maija, et al.
Publicado: (2022)

Elevated serum chemokine CCL22 levels in first-episode psychosis: associations with symptoms, peripheral immune state and in vivo brain glial cell function
por: Laurikainen, Heikki, et al.
Publicado: (2020)

In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis
por: Borgan, Faith, et al.
Publicado: (2019)

S94. PREDICTION OF CANNABIS RELAPSE IN CLINICAL HIGH-RISK INDIVIDUALS AND RECENT ONSET PSYCHOSIS - PRELIMINARY RESULTS FROM THE PRONIA STUDY
por: Penzel, Nora, et al.
Publicado: (2020)

S163. GLUTAMATERGIC METABOLITES IN THE PSYCHOSIS SPECTRUM: FROM HIGH RISK SAMPLES TO FIRST EPISODE PSYCHOSIS
por: Fortea, Adriana, et al.
Publicado: (2020)

S166. EFFECTIVE CONNECTIVITY OF FRONTOSTRIATAL SYSTEMS IN FIRST-EPISODE PSYCHOSIS
por: Sabaroedin, Kristina, et al.
Publicado: (2020)

S150. EMOTIONAL BEHAVIOUR IN HIGH-RISK AND FIRST-EPISODE PSYCHOSIS
por: Falkenberg, Irina, et al.
Publicado: (2020)

S46. IMPAIRED ERROR-PROCESSING IN PATIENTS WITH FIRST-EPISODE PSYCHOSIS: AN EVENT-RELATED POTENTIAL STUDY
por: Park, Jihye, et al.
Publicado: (2020)

S34. EFFECTIVENESS OF INDIVIDUAL METACOGNITIVE TRAINING (MCT+) IN FIRST-EPISODE PSYCHOSIS
por: Ochoa, Susana, et al.
Publicado: (2020)

S129. REHOSPITALIZATION RATE IN PEOPLE WITH FIRST-EPISODE PSYCHOSIS IN THE CZECH REPUBLIC: A REGISTER-BASED STUDY
por: Kondrátová, Lucie, et al.
Publicado: (2020)

Longitudinal brain morphology in anti-NMDA receptor encephalitis: a case report with controls
por: Laurikainen, Heikki, et al.
Publicado: (2019)

S10. SCREENING FOR ANTI-NMDAR ANTIBODIES AMONGST PATIENTS WITH FIRST EPISODE PSYCHOSIS
por: Herman, Levente, et al.
Publicado: (2020)

S25. FRAMEWORK FOR THE CHARACTERIZATION OF HIPPOCAMPUS USING RADIOMIC APPROACH IN FIRST-EPISODE PSYCHOSIS
por: Masias, Mireia, et al.
Publicado: (2020)

S101. DIFFERENTIATING NON-AFFECTIVE ACUTE REMITTING PSYCHOSIS (NARP) FROM SCHIZOPHRENIA IN FIRST-EPISODE PSYCHOSIS: FINDINGS FROM A 3-YEAR LONGITUDINAL STUDY IN THE PAFIP COHORT
por: López-Díaz, Álvaro, et al.
Publicado: (2020)

S79. REINFORCEMENT LEARNING ABNORMALITIES IN INDIVIDUALS AT CLINICAL HIGH RISK AND IN THE FIRST EPISODE OF PSYCHOSIS
por: Datta, Raktima, et al.
Publicado: (2020)

S228. SOCIAL AND OCCUPATIONAL FUNCTIONING AND SATISFACTION WITH CARE IN FINNISH FIRST-EPISODE PSYCHOSIS PATIENTS
por: Barrientos, Paula, et al.
Publicado: (2020)

S232. ASSOCIATIONS OF FOOD CRAVING WITH PSYCHOLOGICAL AND PHYSICAL CHARACTERISTICS IN PATIENTS WITH FIRST-EPISODE PSYCHOSIS
por: Kim, Yeonghyeok, et al.
Publicado: (2020)

S19. THE ROLE OF ACE AS POSSIBLE BIOMARKER FOR TREATMENT RESISTANCE TO ANTIPSYCHOTICS IN FIRST EPISODE OF PSYCHOSIS
por: Luisa, Longo, et al.
Publicado: (2020)

S96. EXAMINING DIFFERENCES BETWEEN CURRENT CANNABIS CONSUMPTION AND COGNITIVE FUNCTIONING OF FIRST-EPISODE PSYCHOSIS PATIENTS: A RETROSPECTIVE STUDY
por: Pochiet, Gabrielle, et al.
Publicado: (2020)

S6. SLEEP ENDOPHENOTYPES OF SCHIZOPHRENIA: A HIGH-DENSITY EEG STUDY IN DRUG-NAïVE, FIRST EPISODE PSYCHOSIS PATIENTS
por: Castelnovo, Anna, et al.
Publicado: (2020)

42.4 THE ENDOCANNABINOID SYSTEM IN FIRST-EPISODE PSYCHOSIS
por: Hietala, Jarmo
Publicado: (2018)

F135. BODY MASS INDEX TRAJECTORIES IN CHILDHOOD AND RISK FOR NON-AFFECTIVE PSYCHOSIS – A GENERAL POPULATION COHORT STUDY
por: Sormunen, Elina, et al.
Publicado: (2018)

S102. DIAGNOSTIC CHALLENGES AT TIME OF INPATIENT ADMISSION: DIAGNOSTIC SHIFTS IN PATIENTS WITH FIRST EPISODE PSYCHOSIS
por: Koch, Marlene, et al.
Publicado: (2020)

S137. LEFT HEMISPHERE MEG DEFICIT IN PITCH AND DURATION MISMATCH NEGATIVITY IN FIRST EPISODE PSYCHOSIS
por: Duricy, Erin, et al.
Publicado: (2020)

S70. PROFILES OF SOCIAL COGNITION AND METACOGNITION IN FIRST-EPISODE PSYCHOSIS: A LATENT PROFILE ANALYSIS
por: Ferrer-Quintero, Marta, et al.
Publicado: (2020)

S18. STRUCTURAL COVARIANCE PREDICTORS OF CLINICAL IMPROVEMENT AT 2-YEAR FOLLOW-UP IN FIRST-EPISODE PSYCHOSIS
por: Saiz-Masvidal, Cristina, et al.
Publicado: (2020)

S224. TREATMENT IN THE PSYCHOSIS FIRST EPISODE PROGRAM “ZüRCHER ERSTPSYCHOSEN NETZWERK (ZEN)”: QUALITY CONTROL OF THE OUTCOME
por: Metzler, Sibylle, et al.
Publicado: (2020)

S115. EVALUATION OF THE CLINICAL UTILITY OF SYMPTOM DIMENSIONS ON LONG-TERM CLINICAL AND FUNCTIONAL OUTCOMES IN FIRST EPISODE PSYCHOSIS
por: Bor, Ege, et al.
Publicado: (2020)

S72. MCCB COGNITIVE PROFILE IN CHINESE FIRST EPISODE SCHIZOPHRENIA PATIENTS AND SUBJECTS AT CLINICAL HIGH RISK FOR PSYCHOSIS
por: Lei, Zhao, et al.
Publicado: (2020)

S186. THE EFFECTS OF CHILDHOOD TRAUMA ON HIPPOCAMPAL VOLUME IN FIRST EPISODE PSYCHOSIS: DOES CORTISOL PLAY A ROLE?
por: Ciufolini, Simone, et al.
Publicado: (2020)

S107. RANDOMIZED CONTROL TRIAL OF A MOBILE APP-BASED INTERVENTION FOR ADOLESCENTS WITH FIRST-EPISODE PSYCHOSIS: THE THINK APP
por: Calvo, Ana, et al.
Publicado: (2020)

S122. TEN-YEAR FOLLOW-UP AFTER FIRST EPISODE PSYCHOSIS: FOCUSED ON LOW DOSE ANTIPSYCHOTIC MAINTENANCE AND FUNCTIONING
por: Liu, Chen-Chung, et al.
Publicado: (2020)

S124. EXAMINING THE CLINICAL AND NEUROCOGNITIVE CHARACTERISTICS OF FIRST-EPISODE PSYCHOSIS PATIENTS WHO WILL NEVER RELAPSE OVER 10 YEARS
Publicado: (2020)

S95. DIFFERENCES IN LIFETIME PATTERNS OF PSYCHOSTIMULANTS AND THEIR IMPACT ON THE PROPORTION OF PATIENTS WITH FIRST-EPISODE PSYCHOSIS ATTRIBUTABLE TO PSYCHOSTIMULANTS USE ACROSS EUROPE
por: Duran-Cutilla, Manuel, et al.
Publicado: (2020)

T7. UPDATED INDIVIDUAL PARTICIPANT DATA META-ANALYSIS CONFIRMS LOWER LEVELS OF THE GLIAL MARKER TSPO IN PSYCHOSIS PATIENTS
por: Plavén-Sigray, Pontus, et al.
Publicado: (2020)

Links between central CB1-receptor availability and peripheral endocannabinoids in patients with first episode psychosis
por: Dickens, Alex M., et al.
Publicado: (2020)

The neural and molecular basis of working memory function in psychosis: a multimodal PET-fMRI study
por: Borgan, Faith, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vjhdi0j1togjtd3c1mp6j20b6c